Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital Image Hub Integrated with Whole-Slide Informatics Solutions

By LabMedica International staff writers
Posted on 01 Sep 2011
An integrated digital pathology software offering will allow those using image analysis and stereology in digital pathology to achieve a streamlined workflow.

Leica Microsystems' (Wetzlar, Germany) SlidePath digital image hub is being integrated with Visiopharm's (Medicon Valley, Denmark) whole-slide informatics solutions. More...
Users can now take advantage of superior image capture and management from Leica Microsystems and excellent Whole Slide image analysis and Whole Slide Stereology from Visiopharm in a single system.

All images stored on the Digital Image Hub server can be browsed and accessed via the Visiopharm software. Selected images are then easily opened and analyzed by either Visiopharm’s image analysis software or stereology software. Following analysis, users can quickly view the resulting data and associated slides through the Visiopharm software interface.

Leica’s Digital Image Hub, developed by SlidePath, is a scalable enterprise-level solution for the management and archiving of digital slides and associated data. The Digital Image Hub is accessed via a standard internet browser and supports images from a variety of digital slide scanners.

The Stavanger University Hospital (Norway) has chosen Leica Microsystems’ Total Digital Pathology solution for scanning and storage of digital slides, and the Visiopharm solution for image analysis.

Dr. Kjell H Kjellevold, head of the hospital's pathology department said, “For us, the combination of these two systems is ideal. The speed and image quality of the Leica SCN400 slide scanner combined with the Digital Image Hub management solution is exactly what is required for making Digital Pathology feasible for research work. The image analysis software from Visiopharm consolidates simplicity for routine work and the flexibility for research. This, together with the low costs of learning and computation, was critical for our decision.”

Related Links:
Leica Microsystems
Visiopharm
Stavanger University Hospital


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.